Zobrazeno 1 - 10
of 4 891
pro vyhledávání: '"Lavanchy D"'
Autor:
FitzSimons, D, François, G, De Carli, G, Shouval, D, Prüss-Üstün, A, Puro, V, Williams, I, Lavanchy, D, De Schryver, A, Kopka, A, Ncube, F, Ippolito, G, Van Damme, P
Publikováno v:
Occupational and Environmental Medicine, 2008 Jul 01. 65(7), 446-451.
Externí odkaz:
https://www.jstor.org/stable/25835234
Autor:
Lavanchy, D.
Publikováno v:
In Clinical Microbiology and Infection February 2011 17(2):107-115
Autor:
Zuckerman, A. J., Lavanchy, D.
Publikováno v:
BMJ: British Medical Journal, 1999 Sep . 319(7213), 799-800.
Externí odkaz:
https://www.jstor.org/stable/25185872
The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e372284c07cc03239a409acf66c525eb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000058
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000058
Autor:
Lavanchy, D.
Publikováno v:
In Journal of Clinical Virology 2005 34 Supplement 1:S1-S3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Vaccine 2002 20 Supplement 2:S5-S14
Autor:
Bihl F; Gastroenterology and Hepatology Department, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Divisions of Gastroenterology and Hepatology, University Hospital, Geneva, Switzerland., Bruggmann P; Arud Centre for Addiction Medicine, Zurich, Switzerland., Castro Batänjer E; Hepatitis C Virtual Clinic and Private Practice, Lausanne, Switzerland., Dufour JF; University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland., Lavanchy D; Consultant, Denges VD, Switzerland., Müllhaupt B; Swiss HPB (Hepato-Pancreato-Biliary) Center and Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland., Negro F; Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospital, Genève, Switzerland., Razavi H; CDA Foundation, Lafayette, Colorado, USA., Scheidegger C; Private Practice, Basel, Switzerland., Semela D; Division of Gastroenterology & Hepatology, Cantonal Hospital, St. Gallen, Switzerland., Semmo N; Department for BioMedical Research, Hepatology, University of Bern, Bern, Switzerland., Blach S; CDA Foundation, Lafayette, Colorado, USA.
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Feb; Vol. 42 (2), pp. 330-339. Date of Electronic Publication: 2021 Dec 10.
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direct acting antiviral therapies. Reliable disease burd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e50dbe3cdec401349680603a5cabd4c1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108884
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108884
Autor:
Lavanchy, D.1 lavanchyd@who.int
Publikováno v:
Journal of Viral Hepatitis. Mar2004, Vol. 11 Issue 2, p97-107. 11p.